In Vivo Mechanisms of Vaccine-Induced Protection against HPV Infection
- 1 September 2010
- journal article
- research article
- Published by Elsevier in Cell Host & Microbe
- Vol. 8 (3) , 260-270
- https://doi.org/10.1016/j.chom.2010.08.003
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendmentsPublished by Elsevier ,2010
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young WomenJNCI Journal of the National Cancer Institute, 2010
- The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface bindingProceedings of the National Academy of Sciences, 2009
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenPublished by Elsevier ,2009
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus VaccinesJNCI Journal of the National Cancer Institute, 2009
- Heparan Sulfate-Independent Cell Binding and Infection with Furin-Precleaved Papillomavirus CapsidsJournal of Virology, 2008
- A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2Journal of Virology, 2007
- Inhibition of Transfer to Secondary Receptors by Heparan Sulfate-Binding Drug or Antibody Induces Noninfectious Uptake of Human PapillomavirusJournal of Virology, 2007
- Neutralization of Human Papillomavirus with Monoclonal Antibodies Reveals Different Mechanisms of InhibitionJournal of Virology, 2007
- Against which human papillomavirus types shall we vaccinate and screen? the international perspectiveInternational Journal of Cancer, 2004